section name header

Table 37.1

Recommended Therapy for Tinea Capitis

Drug

Dosage

Duration

Griseofulvin microsize (liquid 125 mg/5 mL)

20–25 mg/kg/d

6 wk; continue until clinically clear
FDA approved for children >2 y

Griseofulvin ultramicrosize (tablets of varying size)

15 mg/kg/d

6 wk; continue until clinically clear
FDA approved for children >2 y

Terbinafine tablets (250 mg)

4–6 mg/kg/d
10–20 kg: 62.5 mg
20–40 kg: 125 mg
>40 kg: 250 mg

Trichophyton tonsurans: 2–6 wk
Microsporum canis: 8–12 wk
FDA approved for children >4 y

Terbinafine granules (125 mg and 187.5 mg)

<25 kg: 125 mg 25–35 kg: 187.5 mg >35 kg: 250 mg

6-wk duration for all species
FDA approved for children 4 y

Fluconazole

6 mg/kg/d

3–6 wk
FDA approved for the treatment of oral candidiasis in children 6 mo but not approved for the treatment of tinea capitis

Abbreviation: FDA, US Food and Drug Administration.
From American Academy of Pediatrics. Tinea capitis. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red Book: 2018–2021 Report of the Committee on Infectious Diseases. 31st ed. Itasca, IL: American Academy of Pediatrics; 2018:798–801.